nodes	percent_of_prediction	percent_of_DWPC	metapath
Probenecid—SLC22A5—dilated cardiomyopathy	0.403	1	CbGaD
Probenecid—SLC22A11—Furosemide—dilated cardiomyopathy	0.0739	0.158	CbGbCtD
Probenecid—SLCO1A2—Spironolactone—dilated cardiomyopathy	0.0722	0.154	CbGbCtD
Probenecid—ABCC2—Spironolactone—dilated cardiomyopathy	0.0599	0.128	CbGbCtD
Probenecid—SLC22A5—Furosemide—dilated cardiomyopathy	0.0525	0.112	CbGbCtD
Probenecid—SLC22A8—Furosemide—dilated cardiomyopathy	0.043	0.0918	CbGbCtD
Probenecid—ABCC2—Furosemide—dilated cardiomyopathy	0.0409	0.0874	CbGbCtD
Probenecid—SLC22A6—Furosemide—dilated cardiomyopathy	0.0299	0.0639	CbGbCtD
Probenecid—CYP2C8—Spironolactone—dilated cardiomyopathy	0.0288	0.0616	CbGbCtD
Probenecid—ALB—Furosemide—dilated cardiomyopathy	0.0255	0.0545	CbGbCtD
Probenecid—ABCB1—Lisinopril—dilated cardiomyopathy	0.0222	0.0473	CbGbCtD
Probenecid—ABCB1—Spironolactone—dilated cardiomyopathy	0.0195	0.0417	CbGbCtD
Probenecid—CYP2C9—cardial valve—dilated cardiomyopathy	0.00586	0.204	CbGeAlD
Probenecid—PANX1—myocardium—dilated cardiomyopathy	0.00277	0.0966	CbGeAlD
Probenecid—PANX1—heart—dilated cardiomyopathy	0.00193	0.0674	CbGeAlD
Probenecid—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00176	0.0504	CcSEcCtD
Probenecid—SLC2A9—heart—dilated cardiomyopathy	0.00175	0.0611	CbGeAlD
Probenecid—SLC16A7—cardiac ventricle—dilated cardiomyopathy	0.00158	0.055	CbGeAlD
Probenecid—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.0015	0.0428	CcSEcCtD
Probenecid—Procainamide—SCN5A—dilated cardiomyopathy	0.00149	0.634	CrCbGaD
Probenecid—SLC16A7—myocardium—dilated cardiomyopathy	0.00148	0.0517	CbGeAlD
Probenecid—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.00138	0.0394	CcSEcCtD
Probenecid—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00128	0.0366	CcSEcCtD
Probenecid—Alopecia—Spironolactone—dilated cardiomyopathy	0.0012	0.0342	CcSEcCtD
Probenecid—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.00118	0.0337	CcSEcCtD
Probenecid—ABCC5—cardiac ventricle—dilated cardiomyopathy	0.0011	0.0385	CbGeAlD
Probenecid—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00106	0.0302	CcSEcCtD
Probenecid—ABCC5—myocardium—dilated cardiomyopathy	0.00104	0.0362	CbGeAlD
Probenecid—SLC16A7—heart—dilated cardiomyopathy	0.00103	0.0361	CbGeAlD
Probenecid—SLC16A1—cardiac ventricle—dilated cardiomyopathy	0.001	0.035	CbGeAlD
Probenecid—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000963	0.0275	CcSEcCtD
Probenecid—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00096	0.0274	CcSEcCtD
Probenecid—SLC16A1—myocardium—dilated cardiomyopathy	0.000943	0.0329	CbGeAlD
Probenecid—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.000886	0.0253	CcSEcCtD
Probenecid—SLC16A7—cardiac atrium—dilated cardiomyopathy	0.000885	0.0309	CbGeAlD
Probenecid—Procainamide—SLC22A5—dilated cardiomyopathy	0.000857	0.365	CrCbGaD
Probenecid—Pollakiuria—Furosemide—dilated cardiomyopathy	0.000851	0.0243	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000814	0.0233	CcSEcCtD
Probenecid—Urticaria—Spironolactone—dilated cardiomyopathy	0.000765	0.0219	CcSEcCtD
Probenecid—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000761	0.0217	CcSEcCtD
Probenecid—ABCC5—heart—dilated cardiomyopathy	0.000724	0.0252	CbGeAlD
Probenecid—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00072	0.0206	CcSEcCtD
Probenecid—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000709	0.0203	CcSEcCtD
Probenecid—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000697	0.0199	CcSEcCtD
Probenecid—Pruritus—Spironolactone—dilated cardiomyopathy	0.000681	0.0195	CcSEcCtD
Probenecid—SLC16A1—heart—dilated cardiomyopathy	0.000659	0.023	CbGeAlD
Probenecid—Dizziness—Spironolactone—dilated cardiomyopathy	0.000637	0.0182	CcSEcCtD
Probenecid—ABCC5—cardiac atrium—dilated cardiomyopathy	0.000619	0.0216	CbGeAlD
Probenecid—ABCC1—myocardium—dilated cardiomyopathy	0.000613	0.0214	CbGeAlD
Probenecid—Vomiting—Spironolactone—dilated cardiomyopathy	0.000612	0.0175	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000611	0.0175	CcSEcCtD
Probenecid—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000606	0.0173	CcSEcCtD
Probenecid—Headache—Spironolactone—dilated cardiomyopathy	0.000603	0.0172	CcSEcCtD
Probenecid—Anaemia—Furosemide—dilated cardiomyopathy	0.000593	0.017	CcSEcCtD
Probenecid—Haematuria—Lisinopril—dilated cardiomyopathy	0.000587	0.0168	CcSEcCtD
Probenecid—Leukopenia—Furosemide—dilated cardiomyopathy	0.000574	0.0164	CcSEcCtD
Probenecid—SLC22A5—cardiac ventricle—dilated cardiomyopathy	0.000573	0.02	CbGeAlD
Probenecid—Nausea—Spironolactone—dilated cardiomyopathy	0.000572	0.0163	CcSEcCtD
Probenecid—SLC16A1—cardiac atrium—dilated cardiomyopathy	0.000563	0.0196	CbGeAlD
Probenecid—SLC22A5—myocardium—dilated cardiomyopathy	0.000539	0.0188	CbGeAlD
Probenecid—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000524	0.015	CcSEcCtD
Probenecid—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000523	0.0149	CcSEcCtD
Probenecid—ALB—heart—dilated cardiomyopathy	0.000518	0.0181	CbGeAlD
Probenecid—Flushing—Lisinopril—dilated cardiomyopathy	0.000513	0.0147	CcSEcCtD
Probenecid—ABCC4—heart—dilated cardiomyopathy	0.000502	0.0175	CbGeAlD
Probenecid—Anorexia—Furosemide—dilated cardiomyopathy	0.000499	0.0143	CcSEcCtD
Probenecid—Alopecia—Lisinopril—dilated cardiomyopathy	0.000489	0.014	CcSEcCtD
Probenecid—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000455	0.013	CcSEcCtD
Probenecid—Pain—Furosemide—dilated cardiomyopathy	0.000448	0.0128	CcSEcCtD
Probenecid—Anaemia—Lisinopril—dilated cardiomyopathy	0.000445	0.0127	CcSEcCtD
Probenecid—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000431	0.0123	CcSEcCtD
Probenecid—ABCC1—heart—dilated cardiomyopathy	0.000428	0.0149	CbGeAlD
Probenecid—Urticaria—Furosemide—dilated cardiomyopathy	0.000416	0.0119	CcSEcCtD
Probenecid—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000414	0.0118	CcSEcCtD
Probenecid—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000393	0.0112	CcSEcCtD
Probenecid—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000386	0.011	CcSEcCtD
Probenecid—SLC22A5—heart—dilated cardiomyopathy	0.000376	0.0131	CbGeAlD
Probenecid—Anorexia—Lisinopril—dilated cardiomyopathy	0.000375	0.0107	CcSEcCtD
Probenecid—Pruritus—Furosemide—dilated cardiomyopathy	0.000371	0.0106	CcSEcCtD
Probenecid—ABCC1—cardiac atrium—dilated cardiomyopathy	0.000366	0.0128	CbGeAlD
Probenecid—Dizziness—Furosemide—dilated cardiomyopathy	0.000346	0.0099	CcSEcCtD
Probenecid—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000342	0.00976	CcSEcCtD
Probenecid—Pain—Lisinopril—dilated cardiomyopathy	0.000336	0.0096	CcSEcCtD
Probenecid—Vomiting—Furosemide—dilated cardiomyopathy	0.000333	0.00952	CcSEcCtD
Probenecid—Dermatitis—Furosemide—dilated cardiomyopathy	0.00033	0.00943	CcSEcCtD
Probenecid—Headache—Furosemide—dilated cardiomyopathy	0.000328	0.00938	CcSEcCtD
Probenecid—CYP2C9—heart—dilated cardiomyopathy	0.000324	0.0113	CbGeAlD
Probenecid—SLC22A5—cardiac atrium—dilated cardiomyopathy	0.000322	0.0112	CbGeAlD
Probenecid—Urticaria—Lisinopril—dilated cardiomyopathy	0.000312	0.00892	CcSEcCtD
Probenecid—Nausea—Furosemide—dilated cardiomyopathy	0.000311	0.00889	CcSEcCtD
Probenecid—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000311	0.00888	CcSEcCtD
Probenecid—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00029	0.00827	CcSEcCtD
Probenecid—Pruritus—Lisinopril—dilated cardiomyopathy	0.000278	0.00795	CcSEcCtD
Probenecid—Dizziness—Lisinopril—dilated cardiomyopathy	0.00026	0.00743	CcSEcCtD
Probenecid—Vomiting—Lisinopril—dilated cardiomyopathy	0.00025	0.00714	CcSEcCtD
Probenecid—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000248	0.00707	CcSEcCtD
Probenecid—Headache—Lisinopril—dilated cardiomyopathy	0.000246	0.00704	CcSEcCtD
Probenecid—Nausea—Lisinopril—dilated cardiomyopathy	0.000233	0.00667	CcSEcCtD
Probenecid—ABCB1—heart—dilated cardiomyopathy	0.000175	0.00609	CbGeAlD
Probenecid—SLC10A1—Metabolism—SDHA—dilated cardiomyopathy	8.11e-05	0.00129	CbGpPWpGaD
Probenecid—SLC22A5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	8.04e-05	0.00128	CbGpPWpGaD
Probenecid—SLC22A8—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	8.04e-05	0.00128	CbGpPWpGaD
Probenecid—ABCC3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	7.98e-05	0.00127	CbGpPWpGaD
Probenecid—ABCC3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	7.98e-05	0.00127	CbGpPWpGaD
Probenecid—SLC22A8—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	7.82e-05	0.00125	CbGpPWpGaD
Probenecid—SLC22A8—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	7.82e-05	0.00125	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	7.82e-05	0.00124	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—ACTN2—dilated cardiomyopathy	7.72e-05	0.00123	CbGpPWpGaD
Probenecid—ABCC4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	7.71e-05	0.00123	CbGpPWpGaD
Probenecid—PANX1—Innate Immune System—RAF1—dilated cardiomyopathy	7.57e-05	0.0012	CbGpPWpGaD
Probenecid—ABCC4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	7.5e-05	0.00119	CbGpPWpGaD
Probenecid—ABCC4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	7.5e-05	0.00119	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	7.49e-05	0.00119	CbGpPWpGaD
Probenecid—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	7.47e-05	0.00119	CbGpPWpGaD
Probenecid—ABCC3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	7.42e-05	0.00118	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—ANKRD1—dilated cardiomyopathy	7.31e-05	0.00116	CbGpPWpGaD
Probenecid—SLC22A8—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	7.27e-05	0.00116	CbGpPWpGaD
Probenecid—SLCO1A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	7.14e-05	0.00114	CbGpPWpGaD
Probenecid—PANX1—Immune System—CD36—dilated cardiomyopathy	7.05e-05	0.00112	CbGpPWpGaD
Probenecid—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	6.99e-05	0.00111	CbGpPWpGaD
Probenecid—ABCC4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	6.97e-05	0.00111	CbGpPWpGaD
Probenecid—SLCO1A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	6.95e-05	0.00111	CbGpPWpGaD
Probenecid—SLCO1A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	6.95e-05	0.00111	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—TAZ—dilated cardiomyopathy	6.88e-05	0.00109	CbGpPWpGaD
Probenecid—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	6.81e-05	0.00108	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—ANKRD1—dilated cardiomyopathy	6.8e-05	0.00108	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	6.78e-05	0.00108	CbGpPWpGaD
Probenecid—SLC22A6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	6.71e-05	0.00107	CbGpPWpGaD
Probenecid—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	6.68e-05	0.00106	CbGpPWpGaD
Probenecid—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	6.67e-05	0.00106	CbGpPWpGaD
Probenecid—PANX1—Immune System—RAC1—dilated cardiomyopathy	6.65e-05	0.00106	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—VCL—dilated cardiomyopathy	6.57e-05	0.00105	CbGpPWpGaD
Probenecid—SLC22A6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	6.53e-05	0.00104	CbGpPWpGaD
Probenecid—SLC22A6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	6.53e-05	0.00104	CbGpPWpGaD
Probenecid—ABCC2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	6.5e-05	0.00103	CbGpPWpGaD
Probenecid—SLCO1A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	6.46e-05	0.00103	CbGpPWpGaD
Probenecid—ABCC1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	6.43e-05	0.00102	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—TAZ—dilated cardiomyopathy	6.39e-05	0.00102	CbGpPWpGaD
Probenecid—ABCC2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	6.33e-05	0.00101	CbGpPWpGaD
Probenecid—ABCC2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	6.33e-05	0.00101	CbGpPWpGaD
Probenecid—ABCC11—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.31e-05	0.001	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	6.3e-05	0.001	CbGpPWpGaD
Probenecid—ABCC1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	6.25e-05	0.000995	CbGpPWpGaD
Probenecid—ABCC1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	6.25e-05	0.000995	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—SDHA—dilated cardiomyopathy	6.22e-05	0.00099	CbGpPWpGaD
Probenecid—SLC22A6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	6.07e-05	0.000966	CbGpPWpGaD
Probenecid—ABCC2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.88e-05	0.000936	CbGpPWpGaD
Probenecid—SLC2A9—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.86e-05	0.000933	CbGpPWpGaD
Probenecid—ABCC1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.81e-05	0.000925	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—SDHA—dilated cardiomyopathy	5.78e-05	0.00092	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	5.77e-05	0.000918	CbGpPWpGaD
Probenecid—SLC22A2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.6e-05	0.000891	CbGpPWpGaD
Probenecid—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	5.57e-05	0.000886	CbGpPWpGaD
Probenecid—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	5.55e-05	0.000883	CbGpPWpGaD
Probenecid—ABCC4—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	5.46e-05	0.000868	CbGpPWpGaD
Probenecid—SLC22A2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.44e-05	0.000866	CbGpPWpGaD
Probenecid—SLC22A2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.44e-05	0.000866	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—ANKRD1—dilated cardiomyopathy	5.39e-05	0.000858	CbGpPWpGaD
Probenecid—SLC22A12—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.36e-05	0.000853	CbGpPWpGaD
Probenecid—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	5.3e-05	0.000844	CbGpPWpGaD
Probenecid—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	5.3e-05	0.000843	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	5.28e-05	0.000841	CbGpPWpGaD
Probenecid—SLC22A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.22e-05	0.00083	CbGpPWpGaD
Probenecid—PANX1—Innate Immune System—EGFR—dilated cardiomyopathy	5.19e-05	0.000826	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	5.18e-05	0.000824	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	5.15e-05	0.00082	CbGpPWpGaD
Probenecid—ABCC4—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	5.14e-05	0.000818	CbGpPWpGaD
Probenecid—SLC22A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.07e-05	0.000808	CbGpPWpGaD
Probenecid—SLC22A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.07e-05	0.000808	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—TAZ—dilated cardiomyopathy	5.07e-05	0.000807	CbGpPWpGaD
Probenecid—SLC22A2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.06e-05	0.000806	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	4.95e-05	0.000788	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	4.91e-05	0.000782	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	4.87e-05	0.000775	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	4.84e-05	0.000771	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	4.82e-05	0.000767	CbGpPWpGaD
Probenecid—SLC16A7—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.78e-05	0.000761	CbGpPWpGaD
Probenecid—ABCC6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.78e-05	0.000761	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	4.74e-05	0.000754	CbGpPWpGaD
Probenecid—SLC22A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	4.72e-05	0.000751	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—ANKRD1—dilated cardiomyopathy	4.69e-05	0.000747	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	4.62e-05	0.000736	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—SDHA—dilated cardiomyopathy	4.58e-05	0.00073	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—ITGB1—dilated cardiomyopathy	4.42e-05	0.000704	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—TAZ—dilated cardiomyopathy	4.41e-05	0.000702	CbGpPWpGaD
Probenecid—PANX1—Immune System—RAF1—dilated cardiomyopathy	4.41e-05	0.000701	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	4.35e-05	0.000692	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	4.34e-05	0.000691	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—ANKRD1—dilated cardiomyopathy	4.22e-05	0.000672	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	4.22e-05	0.000671	CbGpPWpGaD
Probenecid—ALB—Hemostasis—TTN—dilated cardiomyopathy	4.03e-05	0.000642	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—SDHA—dilated cardiomyopathy	3.99e-05	0.000635	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—TAZ—dilated cardiomyopathy	3.97e-05	0.000632	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	3.96e-05	0.000631	CbGpPWpGaD
Probenecid—ABCC5—Disease—NPPA—dilated cardiomyopathy	3.8e-05	0.000605	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—CD36—dilated cardiomyopathy	3.77e-05	0.0006	CbGpPWpGaD
Probenecid—ABCC5—Disease—PSEN2—dilated cardiomyopathy	3.68e-05	0.000586	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—ANKRD1—dilated cardiomyopathy	3.68e-05	0.000585	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—SDHA—dilated cardiomyopathy	3.59e-05	0.000572	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—RAC1—dilated cardiomyopathy	3.55e-05	0.000566	CbGpPWpGaD
Probenecid—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	3.5e-05	0.000556	CbGpPWpGaD
Probenecid—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	3.49e-05	0.000555	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—TAZ—dilated cardiomyopathy	3.46e-05	0.00055	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—ANKRD1—dilated cardiomyopathy	3.43e-05	0.000546	CbGpPWpGaD
Probenecid—ABCC4—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	3.41e-05	0.000543	CbGpPWpGaD
Probenecid—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	3.39e-05	0.00054	CbGpPWpGaD
Probenecid—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	3.39e-05	0.00054	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—ITGB1—dilated cardiomyopathy	3.3e-05	0.000525	CbGpPWpGaD
Probenecid—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	3.26e-05	0.000518	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—TAZ—dilated cardiomyopathy	3.22e-05	0.000513	CbGpPWpGaD
Probenecid—SLCO1C1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	3.17e-05	0.000504	CbGpPWpGaD
Probenecid—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	3.16e-05	0.000502	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—SDHA—dilated cardiomyopathy	3.13e-05	0.000498	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	3.06e-05	0.000487	CbGpPWpGaD
Probenecid—PANX1—Immune System—EGFR—dilated cardiomyopathy	3.02e-05	0.000481	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.97e-05	0.000473	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.97e-05	0.000473	CbGpPWpGaD
Probenecid—ALB—Hemostasis—VCL—dilated cardiomyopathy	2.97e-05	0.000473	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—SDHA—dilated cardiomyopathy	2.92e-05	0.000464	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—CD36—dilated cardiomyopathy	2.81e-05	0.000448	CbGpPWpGaD
Probenecid—ABCC3—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.8e-05	0.000445	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.77e-05	0.00044	CbGpPWpGaD
Probenecid—ABCC3—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.72e-05	0.000433	CbGpPWpGaD
Probenecid—SLC22A2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	2.68e-05	0.000427	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—RAC1—dilated cardiomyopathy	2.65e-05	0.000422	CbGpPWpGaD
Probenecid—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	2.65e-05	0.000422	CbGpPWpGaD
Probenecid—SLC22A1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	2.5e-05	0.000398	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	2.47e-05	0.000393	CbGpPWpGaD
Probenecid—ABCC3—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.45e-05	0.00039	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.43e-05	0.000388	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	2.42e-05	0.000386	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.37e-05	0.000377	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—RAF1—dilated cardiomyopathy	2.36e-05	0.000375	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	2.34e-05	0.000372	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	2.33e-05	0.00037	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	2.31e-05	0.000367	CbGpPWpGaD
Probenecid—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	2.29e-05	0.000365	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	2.29e-05	0.000365	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—GPX1—dilated cardiomyopathy	2.2e-05	0.000351	CbGpPWpGaD
Probenecid—ABCC1—Disease—NPPA—dilated cardiomyopathy	2.2e-05	0.000349	CbGpPWpGaD
Probenecid—ABCC5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.19e-05	0.000349	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	2.19e-05	0.000349	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	2.17e-05	0.000345	CbGpPWpGaD
Probenecid—ALB—Metabolism—TAZ—dilated cardiomyopathy	2.16e-05	0.000343	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—CD36—dilated cardiomyopathy	2.15e-05	0.000342	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	2.14e-05	0.00034	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	2.13e-05	0.00034	CbGpPWpGaD
Probenecid—ABCC1—Disease—PSEN2—dilated cardiomyopathy	2.13e-05	0.000338	CbGpPWpGaD
Probenecid—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	2.1e-05	0.000335	CbGpPWpGaD
Probenecid—SLC22A11—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.08e-05	0.000331	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	2.06e-05	0.000328	CbGpPWpGaD
Probenecid—SLC22A2—Neuronal System—RAF1—dilated cardiomyopathy	2.05e-05	0.000327	CbGpPWpGaD
Probenecid—SLC16A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.04e-05	0.000325	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	2.01e-05	0.00032	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	2.01e-05	0.00032	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	1.96e-05	0.000312	CbGpPWpGaD
Probenecid—ALB—Metabolism—SDHA—dilated cardiomyopathy	1.95e-05	0.00031	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	1.94e-05	0.000308	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—AGT—dilated cardiomyopathy	1.93e-05	0.000308	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.92e-05	0.000306	CbGpPWpGaD
Probenecid—SLC22A1—Neuronal System—RAF1—dilated cardiomyopathy	1.91e-05	0.000305	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	1.89e-05	0.000301	CbGpPWpGaD
Probenecid—SLC22A7—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.89e-05	0.0003	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	1.88e-05	0.000299	CbGpPWpGaD
Probenecid—ABCC5—Disease—RAC1—dilated cardiomyopathy	1.85e-05	0.000295	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	1.77e-05	0.000281	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—RAF1—dilated cardiomyopathy	1.76e-05	0.00028	CbGpPWpGaD
Probenecid—SLC22A5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.75e-05	0.000279	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	1.75e-05	0.000279	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	1.71e-05	0.000272	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—GPX1—dilated cardiomyopathy	1.69e-05	0.000269	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—CD36—dilated cardiomyopathy	1.65e-05	0.000262	CbGpPWpGaD
Probenecid—ABCC3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.62e-05	0.000258	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	1.6e-05	0.000254	CbGpPWpGaD
Probenecid—SLC22A8—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.59e-05	0.000253	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—GPX1—dilated cardiomyopathy	1.57e-05	0.00025	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	1.54e-05	0.000246	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—CD36—dilated cardiomyopathy	1.53e-05	0.000243	CbGpPWpGaD
Probenecid—ABCC4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.52e-05	0.000242	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.52e-05	0.000242	CbGpPWpGaD
Probenecid—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	1.49e-05	0.000237	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—AGT—dilated cardiomyopathy	1.48e-05	0.000236	CbGpPWpGaD
Probenecid—SLCO1A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.41e-05	0.000224	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—AGT—dilated cardiomyopathy	1.38e-05	0.000219	CbGpPWpGaD
Probenecid—SLC22A6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.32e-05	0.000211	CbGpPWpGaD
Probenecid—ABCC2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.28e-05	0.000204	CbGpPWpGaD
Probenecid—ALB—Hemostasis—CD36—dilated cardiomyopathy	1.27e-05	0.000203	CbGpPWpGaD
Probenecid—ABCC1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.27e-05	0.000202	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—GPX1—dilated cardiomyopathy	1.25e-05	0.000198	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	1.24e-05	0.000197	CbGpPWpGaD
Probenecid—ABCC5—Disease—RAF1—dilated cardiomyopathy	1.23e-05	0.000195	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—CD36—dilated cardiomyopathy	1.21e-05	0.000193	CbGpPWpGaD
Probenecid—ALB—Hemostasis—RAC1—dilated cardiomyopathy	1.2e-05	0.000191	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.2e-05	0.00019	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.19e-05	0.000189	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.17e-05	0.000185	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	1.16e-05	0.000185	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.16e-05	0.000184	CbGpPWpGaD
Probenecid—SLC22A2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.1e-05	0.000176	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—AGT—dilated cardiomyopathy	1.09e-05	0.000174	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—GPX1—dilated cardiomyopathy	1.08e-05	0.000173	CbGpPWpGaD
Probenecid—ABCC1—Disease—RAC1—dilated cardiomyopathy	1.07e-05	0.00017	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.07e-05	0.00017	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—CD36—dilated cardiomyopathy	1.06e-05	0.000168	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	1.05e-05	0.000168	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.05e-05	0.000167	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.04e-05	0.000166	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	1.04e-05	0.000166	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.04e-05	0.000166	CbGpPWpGaD
Probenecid—SLC22A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.03e-05	0.000164	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	9.92e-06	0.000158	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—GPX1—dilated cardiomyopathy	9.76e-06	0.000155	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	9.74e-06	0.000155	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—AGT—dilated cardiomyopathy	9.51e-06	0.000151	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—CD36—dilated cardiomyopathy	9.5e-06	0.000151	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	9.48e-06	0.000151	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	9.36e-06	0.000149	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—AGT—dilated cardiomyopathy	8.56e-06	0.000136	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	8.54e-06	0.000136	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—GPX1—dilated cardiomyopathy	8.5e-06	0.000135	CbGpPWpGaD
Probenecid—ABCC5—Disease—EGFR—dilated cardiomyopathy	8.42e-06	0.000134	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—CD36—dilated cardiomyopathy	8.28e-06	0.000132	CbGpPWpGaD
Probenecid—ALB—Hemostasis—RAF1—dilated cardiomyopathy	7.95e-06	0.000127	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—GPX1—dilated cardiomyopathy	7.92e-06	0.000126	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—CD36—dilated cardiomyopathy	7.71e-06	0.000123	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—AGT—dilated cardiomyopathy	7.45e-06	0.000119	CbGpPWpGaD
Probenecid—ABCC1—Disease—RAF1—dilated cardiomyopathy	7.09e-06	0.000113	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—AGT—dilated cardiomyopathy	6.95e-06	0.000111	CbGpPWpGaD
Probenecid—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.88e-06	0.00011	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.03e-06	9.6e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	5.33e-06	8.48e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GPX1—dilated cardiomyopathy	5.3e-06	8.43e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	5.19e-06	8.26e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CD36—dilated cardiomyopathy	5.16e-06	8.21e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—EGFR—dilated cardiomyopathy	4.86e-06	7.74e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	4.76e-06	7.57e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	4.67e-06	7.44e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—AGT—dilated cardiomyopathy	4.65e-06	7.39e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	4.64e-06	7.39e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	4.63e-06	7.37e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CD36—dilated cardiomyopathy	4.52e-06	7.2e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	4.34e-06	6.9e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	4.22e-06	6.72e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	4.17e-06	6.64e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—AGT—dilated cardiomyopathy	4.07e-06	6.48e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	3.8e-06	6.05e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	2.86e-06	4.55e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	2.79e-06	4.43e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	2.51e-06	3.99e-05	CbGpPWpGaD
